Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model

Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model
复制标题

DOI:
10.1161/01.cir.0000160350.20810.0f
复制
发表时间:
2005-04-05
期刊:
影响因子:
37.8
通讯作者:
Kitakaze, M
Kitakaze, M
中科院分区:
医学1区
文献类型:
--
作者:
Li, Y;Minamino, T;Kitakaze, M

文献摘要

被引文献

相似文献

背景-平滑肌细胞的迁移、增殖和基质降解蛋白酶表达是血管损伤后内膜增生的主要特征。虽然MEK激酶1(MEKK 1)已被证明可以调节细胞迁移和尿激酶纤溶酶原激活剂(uPA)的表达,MEKK 1在这个过程中的确切作用仍然未知。方法和结果-我们触发了一个血管重塑模型完全结扎的右颈总动脉野生型(WT)和MEKK 1-null(MEKK 1(-/-))小鼠。结扎后28天,MEKK 1(-/-)动脉的内膜面积与WT动脉相比显著减少(28 +/- 8 vs 65 +/- 17 μ m(2),P < 0.05)。WT和MEKK 1(-/-)动脉之间的动脉壁内增殖细胞核抗原(PCNA)阳性细胞与总细胞的比率没有差异。WT和MEKK 1(-/-)培养的主动脉平滑肌细胞(AoSMC)之间的增殖能力也没有差异。相比之下,在MEKK 1(-/-)动脉中,结扎后7天内膜PCNA阳性细胞的数量显著较少。三种不同的迁移实验显示MEKK 1(-/-)AoSMCs的迁移和侵袭能力明显受损。添加全长MEKK 1恢复了MEKK 1(-/-)AoSMC的迁移能力。MEKK 1(-/-)AoSMCs显示由上皮生长因子形成的板状伪足的数量显著小于WT SMCs。结论MEKK 1通过调节平滑肌细胞的迁移和uPA的表达,参与血流阻断后的血管重构。MEKK 1是药物开发的潜在靶点,以防止血管重塑。
Background - Migration, proliferation, and matrix-degrading protease expression of smooth muscle cells (SMCs) are major features of intimal hyperplasia after vascular injury. Although MEK kinase 1 (MEKK1) has been shown to regulate cell migration and urokinase plasminogen activator (uPA) expression, the precise role of MEKK1 in this process remains unknown.Methods and Results - We triggered a vascular remodeling model by complete ligation of the right common carotid artery in wild-type (WT) and MEKK1-null ( MEKK1(-/-)) mice. The intimal areas 28 days after ligation were significantly decreased in the ligated MEKK1(-/-) arteries compared with WT arteries ( 28 +/- 8 versus 65 +/- 17 mu m(2), P < 0.05). There were no differences in the ratios of proliferating cell nuclear antigen ( PCNA) - positive cells to total cells within the arterial wall between WT and MEKK1(-/-) arteries. Proliferation capacity also did not differ between WT and MEKK1(-/-) cultured aortic smooth muscle cells (AoSMCs). In contrast, the number of intimal PCNA-positive cells 7 days after ligation was significantly smaller in MEKK1(-/-) arteries. Three different migration assays revealed that migration and invasion of MEKK1(-/-) AoSMCs were markedly impaired. Addition of full-length MEKK1 restored the migration capacity of MEKK1(-/-) AoSMCs. The number of MEKK1(-/-) AoSMCs showing lamellipodia formation by epithelial growth factor was significantly smaller compared with those of WT SMCs. Furthermore, uPA expression after ligation was markedly decreased in MEKK1(-/-) arteries.Conclusions - MEKK1 is implicated in vascular remodeling after blood-flow cessation by regulating the migration and uPA expression of SMCs. MEKK1 is a potential target for drug development to prevent vascular remodeling.